Literature DB >> 18783392

Mapping the English and Chinese versions of the Functional Assessment of Cancer Therapy-General to the EQ-5D utility index.

Yin-Bun Cheung1, Julian Thumboo, Fei Gao, Gim-Yew Ng, Grace Pang, Wen-Hsin Koo, Vijay-Kumar Sethi, Joseph Wee, Cynthia Goh.   

Abstract

OBJECTIVE: This study aims to develop a function for mapping the English and Chinese versions of the Functional Assessment of Cancer Therapy-General (FACT-G) scores to the EuroQoL Group's EQ-5D utility index and to test whether a single function is sufficient for the two language versions.
METHODS: A baseline survey of 558 cancer patients in Singapore using the FACT-G and EQ-5D was conducted (308 English and 250 Chinese questionnaires). Regression models were used to predict the EQ-5D utility index values based on the FACT-G scores and thus derive a mapping equation. Data from a follow-up survey of the patients were used to validate the results.
RESULTS: The FACT-G Social/Family scale was not associated with the EQ-5D utility index (P = 0.701). There was no interaction between language version and the predictors (each P > 0.1). An equation that maps the FACT-G Physical, Emotional, and Functional well-being scales to the EQ-5D utility index was derived. In the validation sample, the mean observed utility values was larger than the mapped by only 0.005 (95% confidence interval [CI]-0.006 to 0.016), but the mean absolute difference was 0.083 (95% CI 0.076 to 0.090).
CONCLUSIONS: At the group level, but not individual level, the equation developed can accurately map the English and Chinese versions of the FACT-G scores to the EQ-5D utility index.

Entities:  

Mesh:

Year:  2008        PMID: 18783392     DOI: 10.1111/j.1524-4733.2008.00448.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  22 in total

Review 1.  Evaluation of content on EQ-5D as compared to disease-specific utility measures.

Authors:  Fang-Ju Lin; Louise Longworth; A Simon Pickard
Journal:  Qual Life Res       Date:  2012-06-23       Impact factor: 4.147

2.  Mapping the cancer-specific FACT-B onto the generic SF-6Dv2.

Authors:  Azin Nahvijou; Hossein Safari; Mahmood Yousefi; Marziyeh Rajabi; Morteza Arab-Zozani; Hosein Ameri
Journal:  Breast Cancer       Date:  2020-07-25       Impact factor: 4.239

3.  Mapping the Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory to the Health Utility Index Mark III.

Authors:  Yin Bun Cheung; Hui Xing Tan; Vivian Wei Wang; Nagaendran Kandiah; Nan Luo; Gerald C H Koh; Hwee Lin Wee
Journal:  Qual Life Res       Date:  2018-09-01       Impact factor: 4.147

4.  Mapping Between the Sydney Asthma Quality of Life Questionnaire (AQLQ-S) and Five Multi-Attribute Utility Instruments (MAUIs).

Authors:  Billingsley Kaambwa; Gang Chen; Julie Ratcliffe; Angelo Iezzi; Aimee Maxwell; Jeff Richardson
Journal:  Pharmacoeconomics       Date:  2017-01       Impact factor: 4.981

5.  Predicting EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) Utilities from Older People's Quality of Life Brief Questionnaire (OPQoL-Brief) Scores.

Authors:  Billingsley Kaambwa; Julie Ratcliffe
Journal:  Patient       Date:  2018-02       Impact factor: 3.883

6.  Cost effectiveness of cetuximab concurrent with radiotherapy for patients with locally advanced head and neck cancer in Taiwan: a decision-tree analysis.

Authors:  Agnes L F Chan; Henry W C Leung; Shiao-Feng Huang
Journal:  Clin Drug Investig       Date:  2011-10-01       Impact factor: 2.859

7.  Mapping the Shah-modified Barthel Index to the Health Utility Index Mark III by the Mean Rank Method.

Authors:  Yin Bun Cheung; Hui Xing Tan; Nan Luo; Hwee Lin Wee; Gerald C H Koh
Journal:  Qual Life Res       Date:  2019-07-27       Impact factor: 4.147

8.  Mapping utility scores from the Barthel index.

Authors:  Billingsley Kaambwa; Lucinda Billingham; Stirling Bryan
Journal:  Eur J Health Econ       Date:  2011-11-02

9.  Comparison of methods to estimate health state utilities for ovarian cancer using quality of life data: a Gynecologic Oncology Group study.

Authors:  Lisa M Hess; William E Brady; Laura J Havrilesky; David E Cohn; Bradley J Monk; Lari Wenzel; David Cella
Journal:  Gynecol Oncol       Date:  2012-10-30       Impact factor: 5.482

10.  The ability of cancer-specific and generic preference-based instruments to discriminate across clinical and self-reported measures of cancer severities.

Authors:  Paulos Teckle; Stuart Peacock; Helen McTaggart-Cowan; Kim van der Hoek; Stephen Chia; Barb Melosky; Karen Gelmon
Journal:  Health Qual Life Outcomes       Date:  2011-11-28       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.